As clinicians, we love that
Its a move that may not be surprising, considering the impact of blockbuster weight-loss drugs and the consumer shift toward longevity-supporting measures
RELATED STORY | Medicare will start covering weight-loss drugs on July 1 for the first time Advertisement The company said the ads also lead consumers to believe Eli Lilly's medication is superior to Novo Nordisk's
GLP-1 Orders for Patients with Diabetes Q1 2026 Quarterly rates per 100,000 of patients with documentation of type 2 diabetes and receiving clinical care receiving a prescription, dispense, or reporting starting a GLP-1 medication
Some patients respond better to one GLP-1 drug than another due to genetic variation in GLP1R gene expression or differences in how their bodies metabolize each compound
Further subgroup analyses showed that patients who had undergone radiotherapy or concurrent chemoradiotherapy also exhibited lower DRS values and worse survival outcomes, implying that such pretreated patients may be particularly responsive to sermorelin [1] Finally, univariate and multivariate Cox regression analyses were performed to determine whether DRS was an independent prognostic factor